Merck Company Stock Book Value Per Share
| 0QAH Stock | USD 103.50 27.80 21.17% |
Merck Company fundamentals help investors to digest information that contributes to Merck's financial success or failures. It also enables traders to predict the movement of Merck Stock. The fundamental analysis module provides a way to measure Merck's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck stock.
Merck | Book Value Per Share |
Merck Company Company Book Value Per Share Analysis
Merck's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Merck Book Value Per Share | 15.24 X |
Most of Merck's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck Company is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
Merck Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, the book value per share of Merck Company is about 15.237 times. This is 996.29% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The book value per share for all United Kingdom stocks is 99.21% higher than that of the company.
Merck Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merck's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merck could also be used in its relative valuation, which is a method of valuing Merck by comparing valuation metrics of similar companies.Merck is currently under evaluation in book value per share category among its peers.
Merck Fundamentals
| Return On Equity | 0.0761 | ||||
| Return On Asset | 0.0512 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 286.09 B | ||||
| Shares Outstanding | 2.54 B | ||||
| Shares Owned By Insiders | 0.08 % | ||||
| Shares Owned By Institutions | 77.64 % | ||||
| Price To Book | 8.24 X | ||||
| Price To Sales | 4.50 X | ||||
| Revenue | 60.12 B | ||||
| Gross Profit | 42.08 B | ||||
| EBITDA | 12.33 B | ||||
| Net Income | 365 M | ||||
| Cash And Equivalents | 7 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 1.37 B | ||||
| Debt To Equity | 1.16 % | ||||
| Book Value Per Share | 15.24 X | ||||
| Cash Flow From Operations | 13.01 B | ||||
| Earnings Per Share | 1.22 X | ||||
| Price To Earnings To Growth | 0.10 X | ||||
| Number Of Employees | 67 K | ||||
| Beta | 0.38 | ||||
| Market Capitalization | 262.63 B | ||||
| Total Asset | 106.67 B | ||||
| Retained Earnings | 53.9 B | ||||
| Working Capital | 6.47 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 3.07 % | ||||
| Net Asset | 106.67 B | ||||
| Last Dividend Paid | 2.84 |
About Merck Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck Company's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Company based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.